glp-1 news september 30 2025 drugs are already famous for weight loss, but the OHSU-led trial pushed the story further. Adults with type 1 diabetes using automated insulin delivery and weekly semaglutide were far more What's next for GLP-1 innovation:

Less common, more critical The serious side effects listed in the safety warnings for semaglutide and tirzapetide include changes in vision, while tirzapetide lists the possibility of diabetic retinopathy complications

It may not be recommended for people with uncontrolled high blood pressure, certain cardiovascular conditions, or for women who are pregnant or breastfeeding

Adding obesity to that equation compounds the danger significantly

The duration depends on your usage volume

By stimulating these receptors, these medications help create a feeling of fullness, slow down digestion, and stabilize blood sugar levelsall essential factors for effective weight loss

Recent studies have raised concerns about a higher risk of gastroparesis in GLP-1 medication users